Evidence map›Paper›PMID 32114525›Full record

ReviewRadiology and oncology2020

Surgical options in treating patients with primary hyperparathyroidism.

Masa Majcen, Marko Hocevar

Abstract readReview
In one paragraph

Review in Radiology and oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. [Comparative study of the efficacy of subclavian space endoscopic approach and anterior cervical open surgery for the treatment of hyperparathyroidism].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Article
  2. Article
  3. Observational
  4. Article
  5. Hyperparathyroidism and Peripheral Arterial Disease.Current vascular pharmacology · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Masa MajcenGeneral Hospital Celje, Celje, Slovenia.
Marko HocevarInstitute of Oncology Ljubljana, Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Primary hyperparathyroidism is the third most common endocrine disorder for which surgical procedure called parathyroidectomy is the most effective treatment. Since the early 20th century, parathyroid surgery has improved extensively. With the advances in preoperative imaging and with understanding the causes of disease, new and minimally invasive surgical approaches overrode the standard bilateral exploratory operations. Directed parathyroidectomy is currently the standard technique for treatment of primary hyperparathyroidism worldwide. Conclusions Surgery is the only definitive treatment of primary hyperparathyroidism. The most appropriate type of surgical procedure depends on the number and localization of the hyperactive parathyroid glands, availability of modern imaging techniques, limitation of each type of procedure and expertise.

Indexed as

Contraindications, ProcedureEndoscopyHumansHyperparathyroidism, PrimaryMinimally Invasive Surgical ProceduresNeckParathyroidectomyParathyroid GlandsPreoperative CareRadiopharmaceuticalsRobotic Surgical ProceduresTechnetium Tc 99m SestamibiTreatment OutcomeVideo-Assisted SurgeryRadiopharmaceuticalsTechnetium Tc 99m Sestamibibilateral neck explorationdirected parathyroidectomyendoscopic parathyroidectomyminimally invasive parathyroidectomyprimary hyperparathyroidism

Identifiers

PMID32114525
PMCPMC7087427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.